Valuation: Carmat SA

Market Cap 61.46L 71.05L 57.39L 52.65L 99.03L 68Cr 1.01Cr 6.73Cr 2.64Cr 34Cr 2.67Cr 2.61Cr 112.05Cr P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 5.92Cr 6.85Cr 5.53Cr 5.08Cr 9.55Cr 651.85Cr 9.7Cr 65Cr 25Cr 326.73Cr 26Cr 25Cr 1.08TCr EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Current year 0.1
Extreme 0.099
0.1
1 year 0.08
Extreme 0.085
0.55
3 years 0.08
Extreme 0.085
9.99
5 years 0.08
Extreme 0.085
31.7
10 years 0.08
Extreme 0.085
44.95
Manager TitleAgeSince
Chief Executive Officer 55 01/09/2016
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/04/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 02/01/2017
Director/Board Member 79 20/04/2017
Date Insider Type Main position Quantity % Market Cap.
13/03/25 Sell

Chairman

13,43,333 2.3347%
13/03/25 Buy

Chairman

13,43,333 2.3347%
29/05/24 Buy

Director

13,43,333 4.6122%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-82.93%-98.65% 70.8L
+0.47%+4.09%-9.92%+18.43% 13TCr
+1.37%-3.93%-17.22%-0.67% 1.26TCr
+5.28%+7.98%+104.57%+139.45% 1.06TCr
+2.59%-3.43%-43.52%-67.91% 470.14Cr
+2.93%+3.12%-22.39%+42.74% 269.84Cr
+2.16%+19.82%-21.92%-77.34% 173.92Cr
+2.82%+0.80%-14.07%-12.55% 168.68Cr
+2.16%-0.93%-31.19%-27.86% 166.15Cr
Average +2.20%+3.25%-15.40%-9.37% 1.84TCr
Weighted average by Cap. +1.01%+3.66%-4.69%+20.88%

Financials

2023 2024
Net sales 38.37L 44.36L 35.83L 32.87L 61.82L 42Cr 62.81L 4.2Cr 1.65Cr 21Cr 1.67Cr 1.63Cr 70Cr 73.44L 84.9L 68.58L 62.91L 1.18Cr 81Cr 1.2Cr 8.05Cr 3.16Cr 41Cr 3.19Cr 3.12Cr 133.89Cr
Net income -5.39Cr -6.23Cr -5.03Cr -4.61Cr -8.68Cr -592.69Cr -8.82Cr -59Cr -23Cr -297.07Cr -23Cr -23Cr -982.11Cr -5.14Cr -5.94Cr -4.8Cr -4.4Cr -8.28Cr -565.47Cr -8.41Cr -56Cr -22Cr -283.43Cr -22Cr -22Cr -937.01Cr
Net Debt 4.96Cr 5.74Cr 4.64Cr 4.25Cr 8Cr 546.12Cr 8.12Cr 54Cr 21Cr 273.73Cr 22Cr 21Cr 904.94Cr 5.31Cr 6.14Cr 4.96Cr 4.55Cr 8.56Cr 584.23Cr 8.69Cr 58Cr 23Cr 292.83Cr 23Cr 23Cr 968.09Cr
Logo Carmat SA
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153
  1. Stock Market
  2. Stocks
  3. ALCAR Stock